Metaflam Easy Chews
$ 70,00 – $ 390,00Price range: $ 70,00 through $ 390,00
Mirapex
$ 30,00 – $ 440,00Price range: $ 30,00 through $ 440,00
Metaflam Oral Suspension
$ 38,00 – $ 77,00Price range: $ 38,00 through $ 77,00
Metaflam Oral Suspension is a highly effective non-steroidal anti-inflammatory drug (NSAID) specifically formulated to manage pain and inflammation in dogs. This medication is primarily used to provide relief from the symptoms of acute and chronic osteoarthritis, helping to improve your pet’s mobility and comfort. The convenient liquid suspension allows for precise dosing and can be easily administered directly into the mouth or mixed with food. By reducing joint swelling and stiffness, Metaflam supports a more active lifestyle and enhances the overall quality of life for your canine companion. Its fast-acting formula ensures reliable relief from musculoskeletal discomfort, helping pets return to their normal daily activities.
SKU:
Metaflam Oral Suspension
Category: Misc
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Metaflam Oral Suspension belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs). It contains meloxicam as its active pharmaceutical ingredient and is formulated as a liquid suspension primarily to manage pain, fever, and localized inflammation associated with specific arthritic disorders.
In accordance with United States Food and Drug Administration (FDA) regulations, this medication is dispensed pursuant to a valid prescription from a licensed healthcare provider. Proper administration requires careful adherence to individualized dosage instructions to achieve therapeutic benefit while minimizing potential systemic risks.
| Parameter | Details |
|---|---|
| Active ingredient (INN) | Meloxicam |
| Therapeutic class | Nonsteroidal Anti-inflammatory Drug (NSAID) |
| Dosage form | Oral suspension |
| Primary purpose | Relief of pain and inflammatory symptoms |
| Prescription status | Prescription only (Rx) |
| Storage | Store at room temperature 68°F to 77°F (20°C to 25°C) |
Pharmacological and Clinical Profile
How the drug works
Meloxicam, the active substance in Metaflam Oral Suspension, exerts its pharmacologic activity by inhibiting the cyclooxygenase (COX) enzyme system. This enzyme is responsible for synthesizing prostaglandins from arachidonic acid. Prostaglandins serve as vital chemical mediators in peripheral tissue injury, signaling pain pathways, promoting fever, and driving localized inflammatory responses. Meloxicam demonstrates preferential selectivity for the COX-2 isoenzyme over COX-1 at lower clinical doses. By reducing localized prostaglandin production, the medication decreases swelling, joint stiffness, and nociceptive pain signaling. However, because COX-1 inhibition is not completely absent, gastric mucosal protection and platelet function may still be affected to varying degrees depending on the total dose and duration of therapy.
Main uses
Metaflam Oral Suspension is clinically indicated for the symptomatic treatment of inflammatory joint conditions. Its primary FDA-approved uses include relieving joint pain, stiffness, and inflammation associated with osteoarthritis and adult rheumatoid arthritis. Additionally, liquid meloxicam formulations are approved for pediatric use to relieve symptoms of juvenile rheumatoid arthritis (JRA) in patients aged two years and older. Use of this medication for acute soft tissue injury, gouty arthritis flares, or other off-label painful conditions must be evaluated and explicitly directed by a prescribing clinician, as non-approved indications fall outside standard therapeutic label recommendations.
Dosing schedule
The dosage of Metaflam Oral Suspension is determined on an individual basis following a thorough clinical assessment by a licensed prescriber. For adult osteoarthritis and rheumatoid arthritis, the starting dose is typically 7.5 mg administered once daily, with a maximum recommended limit of 15 mg per day for patients requiring additional anti-inflammatory control. In pediatric patients with juvenile rheumatoid arthritis, dosage calculations are strictly based on total body weight (generally 0.125 mg/kg once daily, up to a maximum of 7.5 mg daily). The oral suspension must be shaken thoroughly prior to measuring each dose to ensure uniform dispersion of the active ingredient. Patients should always utilize a calibrated oral dosing syringe or measuring device rather than standard kitchen spoons to avoid dosing inaccuracies.
How it’s absorbed and eliminated
Following oral administration, meloxicam displays high oral bioavailability of approximately 89%. Absorption is relatively slow, reaching peak plasma concentration within several hours post-administration. Meloxicam exhibits extensive binding to plasma proteins, predominantly serum albumin, exceeding 99%. The drug is heavily metabolized in the liver primarily via the cytochrome P450 2C9 (CYP2C9) pathway, with minor contributions from CYP3A4, converting the compound into clinically inactive metabolites. Elimination of these metabolites occurs in roughly equal proportions through the urine and feces. The elimination half-life of meloxicam ranges between 15 and 20 hours, supporting a once-daily dosing regimen. Steady-state plasma concentrations are generally attained within 3 to 5 days of uninterrupted daily administration.
Safety Precautions and Interactions
Compatibility with other medicines
Metaflam Oral Suspension carries a notable potential for interactions with numerous drug classes. Co-administration with anticoagulants like warfarin, antiplatelet agents such as aspirin, or selective serotonin reuptake inhibitors (SSRIs) substantially increases the risk of gastrointestinal bleeding. Concomitant administration with antihypertensive medications–including ACE inhibitors, angiotensin receptor blockers (ARBs), and beta-blockers–may reduce their blood pressure-lowering effectiveness. Furthermore, NSAIDs can decrease renal clearance of lithium, leading to increased serum lithium concentrations and heightened toxicity risks. Combining meloxicam with other systemic NSAIDs or oral corticosteroids markedly increases the probability of gastric ulcer formation. Patients should disclose all prescription medications, over-the-counter drugs, and dietary supplements to their healthcare team before starting treatment.
Adverse reactions
Adverse reactions associated with Metaflam Oral Suspension range from mild gastrointestinal symptoms to serious systemic complications. Frequently reported side effects include dyspepsia, nausea, diarrhea, abdominal pain, flatulence, and mild dizziness. Less frequent but severe adverse events include gastrointestinal ulceration, mucosal perforation, active gastrointestinal hemorrhage, and hepatic transaminase elevations. Prolonged administration of NSAIDs can lead to renal papillary necrosis and other functional renal impairments. Hypersensitivity reactions, such as anaphylaxis or severe cutaneous adverse reactions like Stevens-Johnson syndrome, require immediate emergency intervention. Patients experiencing persistent or worsening side effects should notify their healthcare provider promptly.
Important precautions
Metaflam Oral Suspension contains boxed warnings regarding serious cardiovascular and gastrointestinal risks. Nonsteroidal anti-inflammatory drugs increase the risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may manifest early in treatment and escalates with dosage and therapy duration. NSAIDs also increase the risk of serious gastrointestinal events, including ulceration, bleeding, and stomach or intestinal perforation. The medication is strictly contraindicated for perioperative pain management in the setting of coronary artery bypass graft (CABG) surgery. Use during late pregnancy (starting at 30 weeks gestation) is contraindicated due to the risk of premature closure of the fetal ductus arteriosus and potential fetal renal impairment. Patients with severe renal dysfunction or hepatic impairment require close monitoring or alternative therapeutic options.
Food and alcohol interactions
Taking Metaflam Oral Suspension with food does not significantly alter the overall extent of systemic absorption, but it can assist in mitigating local gastric irritation. Patients who experience stomach discomfort after taking the medication on an empty stomach are advised to take their dose with food or milk. Conversely, alcohol consumption should be strictly limited or avoided entirely during treatment. Alcohol acts as an independent gastric irritant, and combining it with systemic NSAID therapy substantially elevates the baseline risk of mucosal erosions, peptic ulcers, and upper gastrointestinal hemorrhage.
Red flags
Patients receiving Metaflam Oral Suspension must remain vigilant for clinical signs of dangerous side effects. If red flag symptoms manifest, medication should be discontinued immediately, and urgent medical help should be obtained.
| Red Flag Symptom | Potential Underlying Issue |
|---|---|
| Swelling of the face, lips, tongue, or throat | Severe allergic reaction (Anaphylaxis) |
| Shortness of breath or difficulty breathing | Bronchospasm or acute hypersensitivity |
| Black, tarry, or visibly bloody stools | Upper or lower gastrointestinal bleeding |
| Vomiting blood or coffee-ground material | Acute gastric mucosal ulceration/bleeding |
| Chest pain, sudden weakness, or slurred speech | Thrombotic cardiovascular event or stroke |
| Severe skin rash, blistering, or skin peeling | Stevens-Johnson syndrome or toxic epidermal necrolysis |
Storage and expiration
Metaflam Oral Suspension must be stored at controlled room temperature, ideally between 68°F and 77°F (20°C to 25°C), with brief excursions permitted between 59°F and 86°F (15°C to 30°C). Keep the original container tightly closed and upright to protect the contents from excess moisture and direct light exposure. Protect the liquid formulation from freezing conditions. Store out of the reach of children and domestic pets. Do not use the medicine past the expiration date clearly stamped on the bottle or carton. Unused or expired medication should be disposed of through community pharmacy take-back initiatives or in accordance with local environmental regulations.
What to ask your provider
Prior to starting treatment with Metaflam Oral Suspension, patients are encouraged to discuss their medical baseline with their prescriber. Essential questions include reviewing underlying cardiovascular risk factors, renal function history, and pre-existing gastrointestinal conditions. Patients should verify whether their current routine medications interact with meloxicam and clarify the expected duration of treatment. Inquiring about necessary monitoring protocols–such as baseline blood pressure checks or periodic kidney function blood tests–helps maintain a safe treatment routine.
Common questions
What should I do if a dose of Metaflam Oral Suspension is missed?
If a dose is missed, administer it as soon as remembered unless it is nearly time for the next scheduled dose. Patients should skip the missed dose and resume their regular timing if the next dose is due shortly. Never double the dose to compensate for a missed administration, as taking extra medication elevates the risk of toxic gastrointestinal and renal effects.
How does an oral liquid suspension compare to solid tablet formulations?
The liquid suspension form provides equivalent systemic exposure to tablet formulations while allowing for flexible dosage adjustments. This is particularly advantageous for pediatric patients or adults with difficulty swallowing solid oral dosage forms. The suspension must be shaken thoroughly before each dose to ensure uniform concentration.
Can Metaflam Oral Suspension affect blood pressure measurements?
Yes, NSAIDs including meloxicam can trigger new-onset hypertension or worsen existing high blood pressure. Fluid retention and altered renal hemodynamics contribute to this effect. Regular blood pressure monitoring is recommended during ongoing therapy.
Is it safe to take over-the-counter pain relievers while using Metaflam Oral Suspension?
No, combining Metaflam Oral Suspension with over-the-counter NSAIDs like ibuprofen or naproxen increases the risk of serious side effects without providing additional pain relief. Patients should consult their prescriber before taking any supplemental pain medications, including acetaminophen.
How long does it take for Metaflam Oral Suspension to show therapeutic results?
Initial pain reduction may occur within a few hours following the first dose. However, maximum anti-inflammatory benefits for chronic conditions like rheumatoid arthritis or osteoarthritis typically require several days to two weeks of continuous daily administration.
This text is for informational purposes only and does not constitute individual medical advice. In accordance with FDA requirements.
Additional information
| Dosage |
15 ml |
|---|---|
| Package |
3 bottles ,6 bottles ,8 bottles |
| Active Ingredient |
Meloxicam |
Related products
Bioclan Oral Solution
$ 31,00 – $ 71,00Price range: $ 31,00 through $ 71,00
More Details
This product has multiple variants. The options may be chosen on the product page
Bonhans
$ 87,00 – $ 161,00Price range: $ 87,00 through $ 161,00
More Details
This product has multiple variants. The options may be chosen on the product page
Carodyl Chewable
$ 116,00 – $ 1 139,00Price range: $ 116,00 through $ 1 139,00
More Details
This product has multiple variants. The options may be chosen on the product page
Evion Softgel
$ 56,00 – $ 860,00Price range: $ 56,00 through $ 860,00
More Details
This product has multiple variants. The options may be chosen on the product page
Folitas
$ 60,00 – $ 147,00Price range: $ 60,00 through $ 147,00
More Details
This product has multiple variants. The options may be chosen on the product page
Kenadion Injection
$ 70,00 – $ 240,00Price range: $ 70,00 through $ 240,00
More Details
This product has multiple variants. The options may be chosen on the product page
Kiwof Plus Easy Chews
$ 37,00 – $ 94,00Price range: $ 37,00 through $ 94,00
More Details
This product has multiple variants. The options may be chosen on the product page
Safeheart Soft
$ 44,00 – $ 114,00Price range: $ 44,00 through $ 114,00
More Details
This product has multiple variants. The options may be chosen on the product page
